Category: Science
Scientific articles about the coronavirus
Italy: Mandatory self-isolation for Covid-19 returns
Italy is ramping up its Covid-19 winter wave preparations by announcing the return of mandatory self-isolation for those who test positive for the virus. More...
Russia: Second highest-ever peak of Covid-19 cases
Russia has seen a steady increase in Covid-19 cases over the past three weeks, and the second-highest ever wave of the pandemic in Russia was reported on the 27th August 2022 by OurWorldinData. More...
Federal Reserve: Cognitive difficulties in 62 percent of adults with long COVID
“A degree of cognitive difficulty is especially common, cited by 62 percent of adults who currently report long-term COVID symptoms compared with 30 percent of those who have never had long-term symptoms.” More...
Preprint: Severe organ damage in zebrafish infected with SARS-CoV-2
“Our studies revealed that zebrafish showed inflammatory reaction to SARS-CoV-2 rSpike protein which provoked damage to organs (liver, kidney, ovaries and brain) …and resulted in 78.6% of survival rate in female adults during the first seven days.” More...
Preprint: BA.2.75 centaurus may be much more infective than pre-existing variants
“These results suggest that BA.2.75 can cause more severe respiratory disease than BA.5 and BA.2.” More...
Brazil: First case of monkeypox in a dog
The Brazilian Ministry of Health has been notified of the first confirmed case of monkeypox in a domestic animal. More...
Australia: 12% of the workforce off sick with long Covid
An estimated 31,000 Australian workers are calling in sick every day because of the debilitating symptoms of long COVID. More...
XAY Delta-Omicron recombinant under observation
A new SARS-CoV-2 recombinant lineage from South Africa has been highlighted by Tulio de Oliveira, Director of the Centre for Epidemic Response & Innovation in South Africa today. More...
CDC: Advice for schools on monkeypox
What should we do if a person who has been exposed to monkeypox develops symptoms while in our setting? More...
Research: Paxlovid of no benefit to the under-65’s
“Among patients 65 years of age or older, the rates of hospitalization and death due to Covid-19 were significantly lower among those who received nirmatrelvir than among those who did not. More...